Even though one might assume these results suggest that SETD7 could serve as a prognostic marker for luminal tumours in stage 2, this was not confirmed when we pooled stage 2 samples of luminal subtypes from TCGA PanCancer or METABRIC cohorts (not shown). The gene discussed is SETD7; the disease is neoplasm.